Home » Cancer Articles » Eidogen-Sertanty to Release Oncology Database
Eidogen-Sertanty to Release Oncology Database
Eidogen-Sertanty, Inc. has announced a new oncology knowledgebase focusing on emerging and hot cancer targets.
SAN DIEGO, CA, August 24, 2011 /Cancer PR News/ -- Eidogen-Sertanty, Inc. has announced a new oncology knowledgebase focusing on emerging and hot targets. Complementing its flagship Kinase Knowledgebase (KKB), Eidogen-Sertanty's Oncology Knowledgebase (OKB) focuses on a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian cancer, Prostate cancer, Skin cancer, and Stomach cancer.
The OKB includes enzymatic and cell-based structure-activity data across Epigenetic targets, orphan nuclear receptors, and transcription factors, and includes data across several G protein-coupled receptors (GPCRs), Matrix Metalloproteinases (MMPs), Proteasomes, Farnesyltransferases, Aromatases, and Phosphodiesterases.
Eidogen-Sertanty's Oncology Knowledgebase will be available for subscription in Q4 of 2011.
For more information, please contact:
Steve Muskal
760-651-2885
pr@eidogen-sertanty.com
Eidogen-Sertanty is a privately held company that is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit http://www.eidogen-sertanty.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Steven Muskal
Eidogen-Sertanty
CEO
3460 Marron Rd Ste 103-475
Oceanside, CA
USA 92056
Voice: 760-651-2885
Fax: 760-775-822-1721
Website: Visit Our Website |
|
|
|
|
|
|
Advertise With Us |
About Us |
Contact Us